Micro Emerging Active

BMY Camzyos Phase 3-Studie erfolgreich

New narrative with limited coverage — still forming.

Score
0,4
Dynamik
▲ 1,0
Artikel
2
Quellen
2

Sentiment Timeline

Event Timeline

Apr 09, 2026
Oxford BioTherapeutics Partners Bristol Myers Squibb On T-Cell Engager Therapies For Solid … Bullish
Apr 02, 2026
Bristol-Myers Squibb (BMY) Announces Positive Data from the Phase 3 SCOUT-HCM Trial … Neutral

Zeitverlauf

Erstmals gesehenApr 02, 2026
Zuletzt aktualisiertApr 02, 2026